Association of Multimorbidity, Disease Clusters, and Modification by Genetic Factors With Risk of Dementia
- PMID: 36125811
- PMCID: PMC9490497
- DOI: 10.1001/jamanetworkopen.2022.32124
Association of Multimorbidity, Disease Clusters, and Modification by Genetic Factors With Risk of Dementia
Abstract
Importance: Individual conditions have been identified as risk factors for dementia; however, it is important to consider the role of multimorbidity, as conditions often co-occur.
Objective: To investigate whether multimorbidity is associated with incident dementia and whether associations vary by different clusters of disease and genetic risk for dementia.
Design, setting, and participants: This population-based prospective cohort study used data from the UK Biobank cohort, with baseline data collected between 2006 and 2010 and with up to 15 years of follow-up. Participants included women and men without dementia and aged at least 60 years at baseline. Medical conditions were captured as part of nurse-led verbal interviews conducted at baseline assessment centers. Data were analyzed from October 2020 to July 2022.
Exposures: The presence of at least 2 long-term conditions from a preselected list of 42 conditions was used to define multimorbidity. High genetic risk for dementia was based on presence of 1 or 2 apolipoprotein (APOE) ε4 alleles.
Main outcomes and measures: The main outcome, incident dementia, was derived from hospital inpatient and death registry records. Associations of multimorbidity with dementia were assessed with Cox proportional hazards models.
Results: A total of 206 960 participants (mean [SD] age, 64.1 [2.9] years, 108 982 [52.7%] women) were included in the final sample, of whom 89 201 participants (43.1%) had multimorbidity. Over a mean (SD) of 11.8 (2.2) years of follow-up, 6182 participants (3.0%) developed dementia. The incidence rate was 1.87 (95% CI, 1.80-1.94) per 1000 person-years for those without multimorbidity and 3.41 (95% CI, 3.30-3.53) per 1000 person-years for those with multimorbidity. In Cox proportional hazards models adjusted for age, sex, ethnicity, education, socioeconomic status, and APOE-ε4 carrier status, multimorbidity was associated with an increased risk of incident dementia (hazard ratio [HR], 1.63 [95% CI, 1.55-1.71]). The highest dementia risk was observed for the hypertension, diabetes, and coronary heart disease cluster (HR, 2.20 [95% CI, 1.98-2.46]) and pain, osteoporosis, and dyspepsia cluster (HR, 2.00 [95% CI, 1.68-2.37]) in women and in the diabetes and hypertension cluster (HR, 2.24 [95% CI, 1.97-2.55]) and coronary heart disease, hypertension, and stroke cluster (HR, 1.94 [95% CI, 1.71-2.20]) in men, compared with no multimorbidity. The associations between multimorbidity and dementia were greater in those with a lower genetic risk of dementia (HR, 1.96 [95% CI, 1.81-2.11]) than in those with a higher genetic risk of dementia (HR, 1.39 [95% CI, 1.30-1.49]). Similar findings were observed when stratifying diseases clusters by genetic risk for dementia.
Conclusions and relevance: These findings suggest that multimorbidity was associated with an increased risk of dementia. The associations varied by clusters of disease and genetic risk for dementia. These findings could help with the identification of individuals at high risk of dementia as well as the development of targeted interventions to reduce or delay dementia incidence.
Conflict of interest statement
Figures
Similar articles
-
Association Between Midlife Risk Factors and Late-Onset Epilepsy: Results From the Atherosclerosis Risk in Communities Study.JAMA Neurol. 2018 Nov 1;75(11):1375-1382. doi: 10.1001/jamaneurol.2018.1935. JAMA Neurol. 2018. PMID: 30039175 Free PMC article.
-
Associations Between Midlife Vascular Risk Factors and 25-Year Incident Dementia in the Atherosclerosis Risk in Communities (ARIC) Cohort.JAMA Neurol. 2017 Oct 1;74(10):1246-1254. doi: 10.1001/jamaneurol.2017.1658. JAMA Neurol. 2017. PMID: 28783817 Free PMC article.
-
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.
-
Effects of the Timing of Intense Physical Activity on Hypertension Risk in a General Population: A UK-Biobank Study.Curr Hypertens Rep. 2024 Feb;26(2):81-90. doi: 10.1007/s11906-023-01278-w. Epub 2023 Nov 10. Curr Hypertens Rep. 2024. PMID: 37948020 Review.
-
Dementia, comorbidity and multimorbidity.Br J Community Nurs. 2024 Jul 2;29(7):321-325. doi: 10.12968/bjcn.2024.0053. Br J Community Nurs. 2024. PMID: 38963276 Review.
Cited by
-
Multimorbidity patterns in dementia and mild cognitive impairment.Front Psychiatry. 2024 Nov 7;15:1432848. doi: 10.3389/fpsyt.2024.1432848. eCollection 2024. Front Psychiatry. 2024. PMID: 39575196 Free PMC article.
-
PheMIME: an interactive web app and knowledge base for phenome-wide, multi-institutional multimorbidity analysis.J Am Med Inform Assoc. 2024 Nov 1;31(11):2440-2446. doi: 10.1093/jamia/ocae182. J Am Med Inform Assoc. 2024. PMID: 39127052 Free PMC article.
-
Essential New Complexity-Based Themes for Patient-Centered Diagnosis and Treatment of Dementia and Predementia in Older People: Multimorbidity and Multilevel Phenomenology.J Clin Med. 2024 Jul 18;13(14):4202. doi: 10.3390/jcm13144202. J Clin Med. 2024. PMID: 39064242 Free PMC article. Review.
-
Life Events and Incident Dementia: A Prospective Study of 493,787 Individuals Over 16 Years.J Gerontol B Psychol Sci Soc Sci. 2024 Sep 1;79(9):gbae114. doi: 10.1093/geronb/gbae114. J Gerontol B Psychol Sci Soc Sci. 2024. PMID: 38943474
-
Characteristics of Older Adults with Alzheimer's Disease Who Were Hospitalized during the COVID-19 Pandemic: A Secondary Data Analysis.Int J Environ Res Public Health. 2024 May 30;21(6):703. doi: 10.3390/ijerph21060703. Int J Environ Res Public Health. 2024. PMID: 38928949 Free PMC article.
References
-
- World Health Organization . Risk reduction of cognitive decline and dementia: WHO guidelines. Accessed August 18, 2022. https://www.who.int/publications/i/item/9789241550543 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
